Boston Scientific Corp (BSX)

Debt-to-capital ratio

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Long-term debt	US$ in thousands	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total stockholders’ equity	US$ in thousands	21,770,000	20,708,000	20,371,000	19,925,000	19,281,000	18,885,000	18,226,000	17,850,000	17,574,000	17,641,000	17,252,000	16,735,000	16,623,000	16,461,000	15,942,000	15,720,000	15,327,000	15,564,000	15,616,000	13,804,000
Debt-to-capital ratio		0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

December 31, 2024 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $21,770,000K)
= 0.00

The debt-to-capital ratio of Boston Scientific Corp has consistently remained at 0.00 from March 2020 to December 2024. This implies that the company has not utilized any debt within its capital structure during this period. A debt-to-capital ratio of 0 indicates that the company's capital structure is fully funded by equity, which can be seen as a positive sign, as it reduces the financial risk associated with debt obligations. It suggests that the company has been financing its operations and investments predominantly through equity financing. However, it is essential to note that while a low debt-to-capital ratio can indicate financial stability, it can also mean that the company may be missing out on potential tax benefits associated with debt financing. Overall, Boston Scientific Corp's consistent zero debt-to-capital ratio signifies a conservative capital structure approach.